MedWatch

GN Hearing CEO: R&D organization is back on top form

After a particularly eventful 2021, GN Hearing CEO Gitte Aabo says the hearing aid manufacturer will have overcome last year’s product delays in the second quarter.

Gitte Aabo, CEO of GN Hearing | Photo: GN Hearing / PR

Last year, hearing aid manufacturer GN Hearing experienced a number of product delays, and also parted with its former head of research and development. Now, GN is back on track and ready to win market shares, says the company’s CEO Gitte Aabo, Danish business daily Børsen reports.

In an interview with Børsen, she refers to GN’s launches in the first quarter of the year of Jabra Enhance Plus and a new hearing aid under the company’s flagship Resound One brand, both of which were delayed last year. Additionally, the company has a new product variant ready on the Resound One platform in the second quarter.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs